effect
season
influenza
vaccin
differ
influenza
season
vaccin
strain
alway
match
circul
strain
antigen
drift
addit
influenza
vaccin
effect
vari
countri
differ
circul
strain
popul
characterist
therefor
effect
control
influenza
countryspecif
influenza
must
monitor
everi
season
recent
testneg
casecontrol
studi
design
wide
use
estim
influenza
studi
design
sampl
collect
patient
influenzalik
ill
ili
influenza
estim
compar
vaccin
statu
patient
test
posit
influenza
test
neg
includ
noninfluenza
respiratori
viru
nirv
case
although
studi
design
allow
reliabl
influenza
estim
nonspecif
immun
induc
influenza
infect
may
effect
estim
hypothesis
influenza
infect
induc
shortterm
nonspecif
immun
reduc
risk
subsequ
nirv
infect
therefor
peopl
vaccin
influenza
less
like
natur
infect
influenza
may
higher
risk
nirv
infect
associ
true
nirvposit
case
like
vaccin
influenza
thu
influenza
estim
testneg
casecontrol
studi
use
influenzaneg
control
includ
nirvposit
case
may
overestim
true
support
evid
limit
recent
testneg
casecontrol
studi
european
countri
demonstr
influenza
laboratoryconfirm
influenza
season
confid
interv
ci
spain
ci
uk
ci
among
vaccin
target
group
eight
eu
member
state
howev
none
studi
consid
effect
nirv
influenza
estim
none
influenza
estim
season
report
asian
countri
includ
japan
previou
studi
conduct
season
demonstr
testneg
casecontrol
studi
use
ridt
result
provid
rapid
estim
influenza
current
studi
estim
influenza
trival
inactiv
vaccin
tiv
medic
attend
laboratoryconfirm
influenza
japan
season
use
multiplex
pcr
explor
differ
influenza
point
estim
use
three
differ
control
influenzaneg
control
nirvposit
control
respiratori
viru
rv
neg
control
studi
approv
institut
review
board
irb
inou
hospit
nagasaki
irb
institut
tropic
medicin
nagasaki
univers
hospit
doctor
inform
studi
object
method
elig
patient
guardian
verbal
consult
also
provid
necessari
inform
patient
guardian
use
standard
questionnair
sheet
poster
present
outpati
depart
requir
obtain
written
consent
waiv
irb
anonym
data
use
analysi
nagasaki
citi
locat
western
part
japan
prospect
casecontrol
studi
conduct
middles
commun
hospit
citi
studi
site
use
previou
influenza
studi
season
patient
visit
outpati
depart
present
ili
administ
rapid
influenza
diagnost
test
ridt
elig
studi
modifi
origin
case
definit
ili
use
eu
countri
adapt
local
context
case
defin
ili
patient
show
sudden
onset
fever
least
one
follow
symptom
cough
runni
nose
sore
throat
headach
myalgia
fatigu
aim
recruit
age
group
number
child
case
limit
hospit
paediatr
depart
case
exclud
meet
ili
case
definit
test
perform
five
day
diseas
onset
test
perform
within
seven
day
previou
test
clinic
sampl
lost
present
week
first
pcrconfirm
influenza
case
studi
period
decemb
april
standardis
questionnair
distribut
outpati
studi
period
collect
epidemiolog
inform
includ
clinic
symptom
date
onset
influenza
vaccin
statu
season
patient
consid
vaccin
vaccin
day
prior
hospit
visit
otherwis
consid
unvaccin
patient
caregiv
ask
fill
questionnair
consult
demograph
clinic
inform
collect
electron
medic
record
set
commerci
ridt
kit
rapidtesta
flu
ii
sekisui
medic
japan
offer
everi
ili
patient
diagnos
influenza
bposit
case
routin
practic
ridt
perform
skill
nurs
laboratori
technician
residu
nasopharyng
swab
temporarili
store
laboratori
depart
hospit
use
ridt
within
week
sampl
transport
institut
tropic
medicin
nagasaki
univers
storag
deep
freezer
use
molecular
test
japan
children
year
age
recommend
receiv
dose
season
influenza
vaccin
other
recommend
receiv
one
dose
ministri
health
labor
welfar
cost
vaccin
elderli
partial
fulli
subsid
local
govern
tiv
produc
domest
manufactur
use
influenza
vaccin
live
attenu
influenza
vaccin
approv
japan
therefor
assum
peopl
report
vaccin
influenza
season
vaccin
tiv
world
health
organ
recommend
vaccin
use
northern
hemispher
influenza
season
contain
like
like
strain
like
compon
strain
use
japan
viral
nucleic
acid
extract
use
qia
viral
rna
minikit
qiagen
inc
valencia
ca
follow
four
multiplex
pcr
assay
perform
sampl
detect
rv
influenza
ab
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
human
parainfluenza
viru
hpiv
type
human
rhinoviru
hrv
human
coronaviru
hcov
human
adenoviru
hadv
human
bocaviru
hbov
detail
multiplex
pcr
assay
publish
elsewher
briefli
revers
transcriptionpcr
rtpcr
assay
perform
use
onestep
rtpcr
kit
qiagen
confirmatori
pcr
perform
use
heminest
pcr
assay
sampl
posit
initi
pcr
test
sampl
posit
multiplex
heminest
pcr
defin
posit
current
studi
pcr
result
ridt
result
use
defin
laboratoryconfirm
influenza
case
ha
subtyp
perform
influenza
aposit
sampl
via
rtpcr
sequenc
influenza
ha
gene
use
previous
publish
method
phylogenet
tree
construct
use
neighborjoin
method
sequenc
refer
strain
use
phylogenet
analysi
obtain
epiflu
databas
global
initi
share
avian
influenza
data
gisaid
patient
categoris
three
group
ili
episod
posit
influenza
b
influenza
posit
case
neg
influenza
posit
noninfluenza
respiratori
virus
nirvposit
control
neg
respiratori
virus
rvneg
control
characterist
studi
patient
compar
outcom
categori
use
chisquar
test
fisher
exact
test
kruskalw
test
depend
natur
variabl
patient
age
categoris
four
group
year
year
year
year
earli
late
phase
influenza
season
defin
week
week
week
use
testneg
casecontrol
studi
design
estim
influenza
specif
case
ili
episod
posit
influenza
andor
b
control
ili
episod
neg
influenza
b
influenzaneg
control
also
estim
influenza
exclud
influenza
bposit
case
influenza
estim
calcul
odd
ratio
logist
regress
model
use
estim
unadjust
adjust
or
age
group
underli
condit
durat
onset
test
month
visit
includ
final
model
exclud
patient
unknown
vaccin
histori
instead
code
miss
valu
unknown
statu
includ
patient
analysi
explor
differ
influenza
estim
control
group
conduct
analys
use
nirvposit
control
rvneg
control
sensit
specif
ridt
detect
influenza
assess
consid
pcr
result
gold
standard
also
estim
influenza
use
ridt
result
compar
use
pcr
result
statist
analys
perform
use
stata
stata
corp
usa
decemb
april
ili
episod
enrol
studi
exclus
episod
meet
ili
case
definit
episod
test
within
day
previou
test
episod
test
day
symptom
onset
episod
associ
lost
clinic
sampl
episod
present
week
first
influenza
case
episod
elig
analys
among
singleposit
influenza
singleposit
influenza
b
one
posit
influenza
b
tabl
influenza
season
start
first
week
reach
peak
week
figur
influenza
b
domin
strain
late
phase
week
week
among
influenza
aposit
sampl
subtyp
influenza
aposit
sampl
posit
strain
unsubtyp
influenza
sampl
neg
strain
collect
sampl
posit
nirv
hrv
lead
viru
identifi
follow
rsv
one
case
posit
influenza
b
hrv
case
classifi
influenza
bposit
case
nirv
identifi
throughout
studi
period
characterist
patient
case
categori
summaris
tabl
influenzaposit
case
younger
influenzaneg
group
nirvposit
case
frequent
vaccin
influenza
group
wherea
characterist
similar
across
case
categori
unadjust
estim
influenza
medic
attend
laboratoryconfirm
influenza
confid
interv
base
use
influenzaneg
control
tabl
control
potenti
confound
includ
age
group
underli
condit
durat
diseas
onset
test
month
visit
adjust
estim
ci
restrict
analysi
influenza
unadjust
adjust
estim
ci
ci
respect
stratifi
studi
season
period
adjust
estim
influenza
ci
earli
phase
week
week
ci
late
phase
week
week
data
shown
tabl
control
limit
rvneg
control
adjust
estim
influenza
becam
ci
control
limit
nirvposit
control
adjust
estim
ci
similar
pattern
observ
estim
influenza
sensit
specif
ridt
detect
influenza
andor
b
ci
ci
respect
unadjust
adjust
estim
influenza
use
ridt
result
ci
ci
respect
total
virus
characteris
phylogenet
analysi
sequenc
sequenc
cluster
within
clade
genet
separ
clade
use
influenza
vaccin
figur
season
also
domin
strain
europ
estim
tiv
laboratoryconfirm
influenza
valu
lower
determin
season
domin
strain
two
reason
propos
explain
low
influenza
europ
first
poor
match
tiv
refer
strain
circul
strain
report
substanti
proport
circul
virus
show
reduc
reactiv
vaccin
viru
use
northern
hemispher
season
second
decreas
influenza
late
phase
season
observ
uk
influenza
decreas
earli
phase
oct
late
phase
feb
addit
influenza
decreas
spain
late
peak
influenza
season
wane
immun
may
reduc
overal
japan
nation
institut
infecti
diseas
report
subtyp
strain
b
base
nation
surveil
season
hi
assay
use
postinfect
ferret
antiserum
rais
vaccin
viru
recommend
influenza
vaccin
show
test
virus
reduct
hi
titr
eightfold
phylogenet
analysi
sequenc
virus
consider
separ
vaccin
refer
strain
vaccin
strain
mismatch
partial
explain
low
influenza
japan
addit
despit
limit
sampl
size
decreas
trend
observ
set
specif
adjust
influenza
earli
phase
late
phase
low
japan
may
explain
combin
vaccin
strain
mismatch
wane
protect
case
europ
current
studi
influenza
estim
use
influenzaneg
control
compar
estim
use
rvneg
control
nipvposit
control
although
confid
interv
wide
overlap
point
estim
highest
use
nirvposit
control
follow
influenzaneg
control
rvneg
control
find
consist
hypothesi
recent
propos
cowl
et
al
accord
theoret
discuss
peopl
natur
infect
influenza
protect
subsequ
nirv
infect
influenza
infect
induc
shortterm
nonspecif
immun
wherea
vaccin
peopl
protect
influenza
infect
higher
risk
nirv
infect
fact
cowl
et
al
conduct
randomis
control
trial
demonstr
tiv
recipi
increas
risk
nirv
infect
hypothesi
true
nirvposit
case
like
vaccin
influenza
thu
testneg
casecontrol
studi
estim
use
nirvposit
control
higher
use
influenzaneg
control
use
rvneg
control
support
find
report
australia
specif
kelli
et
al
conduct
testneg
casecontrol
studi
children
demonstr
influenza
influenzaneg
control
use
nirvposit
control
use
hand
sundaram
et
al
recent
report
differ
use
influenzaneg
control
rvneg
control
testneg
casecontrol
studi
estim
compar
vaccin
statu
influenza
test
posit
test
neg
includ
nirvinfect
case
studi
design
allow
collect
appropri
control
deriv
sourc
popul
case
one
import
assumpt
design
control
drawn
popul
without
consider
vaccin
statu
risk
nirv
infect
high
among
peopl
vaccin
influenza
inclus
nirvposit
case
testneg
control
group
overestim
true
phenomenon
may
observ
current
studi
howev
find
provid
conclus
evid
regard
effect
nirv
estim
also
must
note
nirv
posit
nasopharyng
sampl
necessarili
indic
nirv
diseas
investig
need
evalu
valid
includ
nirvposit
case
testneg
casecontrol
studi
previou
studi
demonstr
testneg
casecontrol
studi
use
ridt
provid
rapid
estim
influenza
clinic
set
current
studi
confirm
influenza
estim
use
ridt
result
adjust
almost
ident
use
pcr
result
adjust
although
use
ridt
tend
underestim
true
ve
consid
nirv
infect
statu
testneg
casecontrol
studi
use
ridt
reliabl
assess
tool
influenza
ve
studi
limit
natur
observ
studi
design
vaccin
histori
taken
questionnair
electron
medic
record
recal
bias
may
affect
estim
although
potenti
confound
consid
unmeasur
confound
socioeconom
statu
may
remain
confid
interv
estim
wide
small
sampl
size
howev
point
estim
low
consist
studi
therefor
believ
increas
number
sampl
fundament
chang
conclus
hand
larger
sampl
size
longer
studi
period
requir
futur
studi
assess
age
group
specif
season
specificeffect
nirv
estim
influenza
limit
japan
season
vaccin
strain
mismatch
wane
protect
may
explain
low
studi
suggest
inclus
nirvposit
case
control
group
may
affect
estim
testneg
casecontrol
studi
investig
warrant
identifi
appropri
control
group
studi
design
